tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
NRXP
NRX Pharmaceuticals
RESEARCH TOOLSreports

NRX Pharmaceuticals (NRXP) Income Statement

852 Followers

NRX Pharmaceuticals Income Statement

Last quarter (Q4 2025), NRX Pharmaceuticals's total revenue was $983.00K, an increase of Infinity% from the same quarter last year. In Q4, NRX Pharmaceuticals's net income was $360.00K. See NRX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Mar 22
Total Revenue
$ 1.23M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 577.00K$ -5.00K$ -5.00K$ -4.00K$ -2.00K
Operating Expenses
$ 16.77M$ 19.70M$ 27.58M$ 44.33M$ 95.20M
Depreciation and Amortization
$ 143.00K$ 5.00K$ 5.00K$ 4.00K$ 2.00K
EBITDA
$ -16.04M$ -24.04M$ -30.02M$ -39.75M$ -93.04M
Operating Income
$ -16.22M$ -19.70M$ -27.59M$ -44.34M$ -95.20M
Other Income/Expenses
$ -12.40M$ -5.42M$ -2.56M$ 4.58M$ 2.14M
Pretax Income
$ -28.62M$ -25.13M$ -30.15M$ -39.75M$ -93.06M
Net Income
$ -28.62M$ -25.13M$ -30.15M$ -39.75M$ -93.06M
Per Share Metrics
Basic EPS
$ -1.34$ -2.39$ -3.98$ -0.60$ -7.44
Diluted EPS
$ -1.34$ -2.39$ -3.98$ -0.60$ -7.44
Weighted Average Shares Outstanding
 21.40M 10.52M 7.58M 65.77M 46.92M
Weighted Average Shares Outstanding (Diluted)
 21.40M 10.52M 7.58M 65.77M 46.92M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History